Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Loren S. Jack"'
Autor:
Mohammad Ali Sadiq, Mohamed Kamel Soliman, Sachin Kedar, Rana Zabad, Loren S. Jack, Quan Dong Nguyen, Neil Jouvenat, Salman Sarwar
Publikováno v:
American Journal of Ophthalmology Case Reports
American Journal of Ophthalmology Case Reports, Vol 4, Iss C, Pp 67-70 (2016)
American Journal of Ophthalmology Case Reports, Vol 4, Iss C, Pp 67-70 (2016)
Purpose Fingolimod is among the first oral disease-modifying agents for the treatment of relapsing-remitting multiple sclerosis (MS). Despite its favorable safety profile, fingolimod may cause macular edema, a significant adverse event, which occurs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb940c77d0343ad03842b42d09022fc2
https://doi.org/10.1016/j.ajoc.2016.09.005
https://doi.org/10.1016/j.ajoc.2016.09.005
Publikováno v:
Kompass Ophthalmologie. 2:60-65
Zwei neuartige Wirkstoffklassen werden derzeit umfassend für die Behandlung der trockenen altersbedingten Makuladegeneration (AMD) untersucht. Emixustat, ein oral einzunehmender Sehzyklus-Inhibitor, und Lampalizumab, ein intravitreal zu verabreichen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be43ea4b536b9d12fcb23a75e56528f3
https://doi.org/10.1159/000447680
https://doi.org/10.1159/000447680
Autor:
Loren S. Jack, Eyal Margalit
Publikováno v:
Current Issues in Age-Related Macular Degeneration. :54-72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40687dac27da005ec4cf0b12d01cb3d0
https://doi.org/10.2217/fmeb2013.13.209
https://doi.org/10.2217/fmeb2013.13.209
Autor:
Nicolas Feltgen, Wafa Omri, Mineo Kondo, Uwe Pleyer, Birgit Lorenz, Maximilian Treder, Frank G Holz, Björn Bachmann, Kengo Ikesugi, Klaus Rohrschneider, Ryohei Miyata, Eckart Bertelmann, Diana V. Do, Aniruddha Agarwal, Loren S. Jack, Muhammad Hassan, Hisashi Matsubara, Lars-Olof Hattenbach, Yasir J. Sepah, Salman Sarwar, Mostafa Hanout, Quan Dong Nguyen, Maki Kobayashi, Mohammad Ali Sadiq, Hideyuki Tsukitome
Publikováno v:
Karger Kompass Pneumologie. 2:1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62ecc3801fdb9b474be45a057f5fb150
https://doi.org/10.1159/000362218
https://doi.org/10.1159/000362218
Publikováno v:
Developments in ophthalmology. 55
Two novel classes of medications are currently under extensive investigation for the treatment of dry age-related macular degeneration (AMD). Emixustat, an orally administered visual cycle inhibitor, and lampalizumab, an intravitreally administered m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::124af56b381b53b729f0c22f6f3bd682
https://pubmed.ncbi.nlm.nih.gov/26501510
https://pubmed.ncbi.nlm.nih.gov/26501510
Two novel classes of medications are currently under extensive investigation for the treatment of dry age-related macular degeneration (AMD). Emixustat, an orally administered visual cycle inhibitor, and lampalizumab, an intravitreally administered m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d627c14c9675f0a0e18f2aecfb54ffe
https://doi.org/10.1159/000438954
https://doi.org/10.1159/000438954
Autor:
Mohammad Ali Sadiq, Loren S. Jack, Mostafa Hanout, Philip J. Bierman, Quan Dong Nguyen, William W. West, William Rhoades, Aniruddha Agarwal
Publikováno v:
Journal of Ophthalmic Inflammation and Infection
Background Mantle cell lymphoma (MCL) is an aggressive subtype of non-Hodgkin’s lymphoma that rarely metastasizes to the iris and the anterior segment. Blastic/pleomorphic morphology is thought to have an adverse effect on prognosis in MCL. MCL is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::530bb60311c929c5c9827a0cd441df4a
http://europepmc.org/articles/PMC4598336
http://europepmc.org/articles/PMC4598336
Publikováno v:
Ophthalmology. 122(8)
In 1957, Sjogren and Larsson described an autosomal recessive syndrome in 28 individuals in northern Sweden who shared the clinical triad of congenital ichthyosis, intellectual disability, and spastic diplegia.1 Ichthyosis is the first sign of Sjogre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::358b06c4cac1d3ab7515216605a884d9
https://pubmed.ncbi.nlm.nih.gov/25784589
https://pubmed.ncbi.nlm.nih.gov/25784589
Publikováno v:
Ophthalmic surgery, lasersimaging retina. 46(6)
Ipilimumab is a novel immunotherapeutic agent that improves survival in patients diagnosed with metastatic melanoma. With the rising incidence of melanoma, the use of this pharmacologic agent is increasing. However, ipilimumab can be associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fecfd560f52872c097b8d88336b945bd
https://pubmed.ncbi.nlm.nih.gov/26114847
https://pubmed.ncbi.nlm.nih.gov/26114847
Publikováno v:
Ophthalmic Plastic & Reconstructive Surgery. 25:155-157
Osteoma is the most common neoplasm of the paranasal sinuses usually involving the frontal sinus. Osteomas are benign, but can cause serious intracranial or orbital complications. The authors report a frontal sinus osteoma with orbital emphysema in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8505cf2495c39f55026b3d6bc86cc8ca
https://doi.org/10.1097/iop.0b013e31819aaf14
https://doi.org/10.1097/iop.0b013e31819aaf14